Europe Influenza Drug Market to 2032
Overview
The Europe Influenza Drug Market is expected to reach a 3.57 USD Billion by 2032 and is projected to grow at a CAGR of 7.36% from 2025 to 2032.
Revenue, 2024 (USD Billion)
2.26
Forecast, 2032 (USD Billion)
3.57
CAGR, 2024 - 2032
7.36%
Report Coverage
Europe
Europe Influenza Drug Market 2018-2032 USD Billion
Europe Influenza Drug Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 2.26 USD Billion
- Projected Market Size (2032): 3.57 USD Billion
- CAGR (2025-2032): 7.36%
Key Findings of Europe Influenza Drug Market
- The Europe Influenza Drug Market was valued at 2.26 USD Billion in 2024.
- The Europe Influenza Drug Market is likely to grow at a CAGR of 7.36% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 3.96 USD Billion
- The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 8.09% during the forecast period from 2024 to 2032.
Europe Influenza Drug Market Scope
Europe Influenza Drug Market Segmentation & Scope
Type
- Influenza C
- Influenza B
- Influenza A
Treatment
- Drugs
- Vaccines
Age
- Adults
- Pediatrics
End User
- Homecare
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Europe Influenza Drug Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 2.26 USD Billion |
| Market Value in 2032 | 3.57 USD Billion |
| CAGR (2025-2032) | 7.36% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Treatment,Age,End User,Distribution Channel,Route of Administration |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 2.26 USD Billion in 2024
- Key Country: U.K., leading in terms of revenue with value of 508.83 USD Million in 2024.
Segments and Scope
-
Europe Influenza Drug Market to 2032, By Type
- Influenza A is the largest segment in Europe Influenza Drug Market to 2032 with a revenue of 1.10 USD Billion in the year 2024.
- Influenza A is the Fastest growing segment in Europe Influenza Drug Market to 2032 with a Growth rate of 7.83 % in forecast period 2025-2032.
-
Europe Influenza Drug Market to 2032, By Treatment
- Vaccines is the largest segment in Europe Influenza Drug Market to 2032 with a revenue of 3.96 USD Billion in the year 2024.
- Vaccines is the Fastest growing segment in Europe Influenza Drug Market to 2032 with a Growth rate of 7.38 % in forecast period 2025-2032.
-
Europe Influenza Drug Market to 2032, By Age
- Pediatrics is the largest segment in Europe Influenza Drug Market to 2032 with a revenue of 1.17 USD Billion in the year 2024.
- Pediatrics is the Fastest growing segment in Europe Influenza Drug Market to 2032 with a Growth rate of 7.78 % in forecast period 2025-2032.
-
Europe Influenza Drug Market to 2032, By End User
- Hospitals is the largest segment in Europe Influenza Drug Market to 2032 with a revenue of 1.66 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Europe Influenza Drug Market to 2032 with a Growth rate of 7.52 % in forecast period 2025-2032.
-
Europe Influenza Drug Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Europe Influenza Drug Market to 2032 with a revenue of 1.29 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Europe Influenza Drug Market to 2032 with a Growth rate of 7.67 % in forecast period 2025-2032.
-
Europe Influenza Drug Market to 2032, By Route of Administration
- Oral is the largest segment in Europe Influenza Drug Market to 2032 with a revenue of 1.02 USD Billion in the year 2024.
- Oral is the Fastest growing segment in Europe Influenza Drug Market to 2032 with a Growth rate of 8.09 % in forecast period 2025-2032.
Europe Influenza Drug Market Company Share Analysis
| Company Name |
|
||
| Sanofi | |||
| AstraZeneca | |||
| GSK plc. | |||
| CSL | |||
| F. Hoffmann-La Roche Ltd. | |||
Europe Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Billion
Europe Influenza Drug Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Influenza Drug Market is segmented based on Segmentation Type,Treatment,Age,End User,Distribution Channel,Route of Administration.
Europe Influenza Drug Market was valued at USD 2.26(Revenue in USD Billion) in 2022.
Europe Influenza Drug Market is projected to grow at a CAGR of 7.36% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the Europe Influenza Drug Market, holding a largest market share of 3.96 USD Billion in 2024
Europe Influenza Drug Market Scope
Europe Influenza Drug Market Segmentation & Scope
Type
- Influenza C
- Influenza B
- Influenza A
Treatment
- Drugs
- Vaccines
Age
- Adults
- Pediatrics
End User
- Homecare
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Frequently Asked Questions
The Europe Influenza Drug Market is segmented based on Segmentation Type,Treatment,Age,End User,Distribution Channel,Route of Administration.
Europe Influenza Drug Market was valued at USD 2.26(Revenue in USD Billion) in 2022.
Europe Influenza Drug Market is projected to grow at a CAGR of 7.36% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Influenza Drug Market for final year is USD 3.57 (USD Billion).
Europe Influenza Drug Market Company Profiling
Frequently Asked Questions
The Europe Influenza Drug Market is segmented based on Segmentation Type,Treatment,Age,End User,Distribution Channel,Route of Administration.
Europe Influenza Drug Market was valued at USD 2.26(Revenue in USD Billion) in 2022.
Europe Influenza Drug Market is projected to grow at a CAGR of 7.36% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Influenza Drug Market for final year is USD 3.57 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.